National Institutes of Health (NIH)

National Institutes of Health (NIH) NIH...Turning Discovery Into Health®
Privacy Policy: http://go.usa.gov/x9svN
Engagement≠endorsement NIH...Turning Discovery Into Health®.

Official Facebook account of the National Institutes of Health. Privacy policy: http://go.usa.gov/x9svN
Comment policy: https://bit.ly/3G6xq94
Engagement ≠ endorsement

NEWS: NIH is awarding $21 million to launch a research program aimed at developing computer-based methods that model and...
09/14/2026

NEWS: NIH is awarding $21 million to launch a research program aimed at developing computer-based methods that model and simulate the self-regulating processes of human hormones, known as hormone homeostasis.

Hormone activity varies widely, creating differences in how women and men react to medications, including varying outcomes to dosing, treatment response, and drug toxicity.

The new program, called the Computational Modeling of Hormone Homeostasis Initiative, will advance human-based, data-driven models tailored to each sex’s complex male/female physiology through advanced computational techniques.

Read the full story ➡️ https://bit.ly/4h56xWy.

📢NIH is seeking an exceptional, visionary leader to serve as Chief of the Virology Branch at the National Institute of A...
09/12/2026

📢NIH is seeking an exceptional, visionary leader to serve as Chief of the Virology Branch at the National Institute of Allergy and Infectious Diseases.

The Chief directs and manages a complex scientific program that stimulates basic, translational, and clinical research. This position will also advance product development for viral infectious diseases of public health importance.

Learn more and apply ➡️ https://bit.ly/4dwXJb4

🔬When scientists first discovered HIV in the early-1980s, the condition was widely seen as a death sentence.Today it is ...
09/11/2026

🔬When scientists first discovered HIV in the early-1980s, the condition was widely seen as a death sentence.

Today it is possible to manage the disease as a chronic condition, thanks in large part to the rise of effective antiretroviral therapies and other treatments.

One such treatment is Lenacapavir, a drug developed partly through early-stage science funded by NIH. Lenacapavir is approved by the U.S. FDA and is delivered to patients as a shot just twice per year.

Learn more ➡️ https://bit.ly/4gYcdSa.

NEWS: Researchers design bone marrow-on-a-chip model to study human immune cells.Read the full story ➡️ https://bit.ly/4...
09/11/2026

NEWS: Researchers design bone marrow-on-a-chip model to study human immune cells.

Read the full story ➡️ https://bit.ly/4rakZ4z

09/11/2026

Twenty-five years ago, our nation was forever changed.

Today, we remember the nearly 3,000 lives taken on September 11, 2001, and honor the first responders who ran toward danger to save others.

In the days and weeks that followed, HHS joined the response, including the Commissioned Corps of the U.S. Public Health Service and personnel from the National Disaster Medical System and the National Pharmaceutical Stockpile, which would later become important parts of HHS Administration for Strategic Preparedness and Response.

We honor all who served, all who sacrificed, and all who still carry the wounds of that day.

We will never forget. 🇺🇸

📣NIH is seeking an exceptional scientist to serve as Chief of the Computational Health Research Branch at the National L...
09/10/2026

📣NIH is seeking an exceptional scientist to serve as Chief of the Computational Health Research Branch at the National Library of Medicine in Bethesda, Maryland.

The successful candidate will set the strategic scientific direction of the Branch, provide leadership and mentorship to Principal Investigators and other scientists, and establish and lead an independent research program.

Learn more and apply ➡️ https://bit.ly/4xddlrj

Allergic and inflammatory conditions are on the rise, and researchers are working to better understand how everyday expo...
09/09/2026

Allergic and inflammatory conditions are on the rise, and researchers are working to better understand how everyday exposures to chemicals and pollutants may play a role.

By participating in this NIH research study, you could help advance our understanding of how environmental factors affect human health.

🔎 Who can participate?
Healthy adults ages 18–80.

🏥 What does participation involve?
• Two 7-day hospital stays spaced 4–6 weeks apart
• Participants remain in the room during each 7-day stay so researchers can carefully control environmental exposures
• Controlled environments with specific air quality, food, and personal care products
• Collection of blood, urine, skin, and other health samples
• Lung, skin, and sensory testing
• Follow-up outpatient visits after each stay

💰 You may be compensated up to $1,600 upon completion of the study.
Questions about what daily life is like during the study, bringing a phone or laptop, meals, or other study procedures? Our recruitment team is happy to help.

📞 833-JOIN-NIH
📧 [email protected]
🔎 NIH Study #002257-I
🔗 https://go.nih.gov/002257

🔬NIH-funded research showed that an estimated 1% to 5% of U.S. first graders deal with various physical, behavior, and/o...
09/09/2026

🔬NIH-funded research showed that an estimated 1% to 5% of U.S. first graders deal with various physical, behavior, and/or cognitive impairments stemming from prenatal exposure to alcohol.

Support is available for women trying to stop drinking during pregnancy.

Talk to your health care provider and learn more about treatment resources ➡️ https://bit.ly/3Xzi1cx

🔬 NIH-funded research is shedding light on genetic risk factors for liver cancer.Researchers analyzed data from more tha...
09/08/2026

🔬 NIH-funded research is shedding light on genetic risk factors for liver cancer.

Researchers analyzed data from more than 290,000 people, including 208,000+ All of Us Research participants, and found that rare variants in the DNA repair genes MSH6 and BRCA2 are associated with a 2–3x higher risk of liver cancer across different populations.

These findings could help guide earlier cancer surveillance and inform targeted treatment options. Read the study: https://bit.ly/4r4kusD

09/05/2026

Cisplatin is one of the most effective cancer drugs we have — but it comes with a tough tradeoff: permanent hearing loss in up to half of patients who receive it.

NIH scientists led by Dr. Lisa Cunningham are testing whether a common cholesterol drug, atorvastatin, can reduce that risk in randomized, placebo-controlled trial.

Learn more about the trial: https://bit.ly/4yh9Xg1

Address

9000 Rockville Pike
Bethesda, MD
20814

Website

Alerts

Be the first to know and let us send you an email when National Institutes of Health (NIH) posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category